Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery
Open Access
- 29 July 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 59 (8), 727-740
- https://doi.org/10.1369/0022155411410885
Abstract
Chemically stabilized small interfering RNA (siRNA) can be delivered systemically by intravenous injection of lipid nanoparticles (LNPs) in rodents and primates. The biodistribution and kinetics of LNP–siRNA delivery in mice at organ and cellular resolution have been studied using immunofluorescence (IF) staining and quantitative polymerase chain reaction (qPCR). At 0.5 and 2 hr post tail vein injection of Cy5-labeled siRNA encapsulated in LNP, the organ rank-order of siRNA levels is liver > spleen > kidney, with only negligible accumulation in duodenum, lung, heart, and brain. Similar conclusions were drawn by using qPCR to measure tissue siRNA levels as a secondary end point. siRNA levels in these tissues decreased by more than 10-fold after 24 hr. Within the liver, LNPs delivered siRNA to hepatocytes, Kupffer cells, and sinusoids in a time-dependent manner, as revealed by IF staining and signal quantitation methods established using OPERA/Columbus software. siRNA first accumulated in liver sinusoids and trafficked to hepatocytes by 2 hr post dose, corresponding to the onset of target mRNA silencing. Fluorescence in situ hybridization methods were used to detect both strands of siRNA in fixed tissues. Collectively, the authors have implemented a platform to evaluate biodistribution of siRNA across cell types and across tissues in vivo, with the objective of elucidating the pharmacokinetic and pharmacodynamic relationship to guide optimization of delivery vehicles.Keywords
This publication has 77 references indexed in Scilit:
- Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the LiverMolecular Therapy, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatmentMolecular Therapy, 2010
- Lentiviral delivery of short hairpin RNAsAdvanced Drug Delivery Reviews, 2009
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in MiceMolecular Therapy, 2009
- A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA DeliveryMolecular Pharmaceutics, 2009
- Polymersome delivery of siRNA and antisense oligonucleotidesJournal of Controlled Release, 2009
- Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysisHistochemistry and Cell Biology, 2009
- A quantitative evaluation of peroxidase inhibitors for tyramide signal amplification mediated cytochemistry and histochemistryHistochemistry and Cell Biology, 2006